53-33-8

Basic information

• Product Name: Paramethasone
• Synonyms: PARAMETHASONE;1,4-PREGNADIEN-6-ALPHA-FLUORO-16-ALPHA-METHYL-11-BETA, 17,21-TRIOL-3,20-DIONE;6a-fluoro-11b,17a,21-trihydroxy-16a-methyl-1,4-pregnadiene-3,20-dione;6-alpha-fluoro-11-beta,17-alpha,21-trihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione;6-alpha-fluoro-16-alpha-methylprednisolone;16a-Methyl-6a-fluoroprednisolone;6a-Fluoro-16a-methylprednisolone;Cortiden
• CAS NO: 53-33-8
• Molecular Formula: C22H29FO5
• Molecular Weight: 392.46
• EINECS: 200-169-2
• Mol File: 53-33-8.mol
• Article Data: 9

Chemical Properties

• Melting Point: 228-241°C
• Boiling Point: 573.5 °C at 760 mmHg
• Flash Point: 300.6 °C
• Appearance: /
• Density: 1.32 g/cm³
• Vapor Pressure: 1.53E-15mmHg at 25°C
• Refractive Index: 1.589
• Storage Temp.: -20°C Freezer
• Solubility: DMSO (Slightly), Methanol (Slightly)
• PKA: 12.34±0.70(Predicted)
• CAS DataBase Reference: Paramethasone(CAS DataBase Reference)
• NIST Chemistry Reference: Paramethasone(53-33-8)
• EPA Substance Registry System: Paramethasone(53-33-8)

Safety Data

• Hazardous Substances Data: 53-33-8(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 53-33-8 differently. You can refer to the following data:
1. Paramethasone, is a fluorinated glucocorticoid, having anti-inflammatory and immunosuppressant properties.
2. Glucocorticoid.

Therapeutic Function

Glucocorticoid

InChI:InChI=1/C22H29FO5/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-20(15,2)19(13)17(26)9-21(14,3)22(11,28)18(27)10-24/h4-5,7,11,13-14,16-17,19,24,26,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20+,21+,22+/m1/s1

Relevant articles and documents

Preparation method of palamethasone acetate and palamethasone

The invention provides a palamethasone acetate and a preparation method of palamethasone, 16-methyl hydroxyl epoxy progesterone is used as an initial raw material, fluorination, bromination, debromination, iodination and replacement reaction are sequentially performed to obtain the palamethasone acetate, and then the palamethasone acetate is hydrolyzed to obtain the palamethasone. The preparation process route provided by the invention has fewer reaction steps, the quality and yield of the product have obvious competitiveness, dangerous chemical processes are not involved, the method is green and clean, and the atom economy is improved; the preparation process has a wide industrial application prospect.

Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity

Mucosal adhesive devices are provided for use in the oral cavity for therapy against infections. The devices are dosage units which comprise a combination of antimicrobial agents such as antifungal agents and anti-inflammatory agents, optionally also a local anesthetic. The dosage units yield a gradual and relatively constant release of the pharmaceuticals over at least a 12-hour period.

Amine containing ester prodrugs of corticosteroids

Novel solution stable ester prodrugs of corticosteroids of the formula STR1